Answer
Para-aminosalicylic acid is proposed to compete with para-aminobenzoic acid (PABA) for dihydropteroate synthetase, an enzyme involved in folate biosynthesis, but its weak inhibition in vitro suggests it may have a different target.
Sources for this answer
- GranupasEurocept International bv · emc · SmPC §5.1 Pharmacodynamic properties · Version 1Document updated
Sources checked